Suppr超能文献

Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.

作者信息

Mizuno N S, Humphrey E W

出版信息

Cancer Chemother Rep. 1969 Sep;53(4):215-21.

PMID:5384462
Abstract
摘要

相似文献

1
Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.阿糖胞苷（NSC - 63878）与1,3 - 双（2 - 氯乙基）- 1 - 亚硝基脲（NSC - 409962）联合治疗对体内肉瘤180和L1210的影响。
Cancer Chemother Rep. 1969 Sep;53(4):215-21.
2
Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
Cancer Chemother Rep. 1971 Jun;55(3):215-20.
3
Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
Cancer Chemother Rep. 1972 Feb;56(1):53-9.
4
1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
Cancer Chemother Rep. 1970 Oct;54(5):347-59.
5
Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.用盐酸1-β-D-阿拉伯呋喃糖基胞嘧啶和1,3-双(2-氯乙基)-1-亚硝基脲对小鼠白血病L1210进行单独和序贯化疗。
Cancer Res. 1967 May;27(5):873-9.
6
1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.1,3-双(2-氯乙基)-1-亚硝基脲（NSC-409962）与甲氨蝶呤（NSC-740）联合治疗晚期小鼠白血病L1210
Cancer Chemother Rep. 1965 Oct;48:35-9.
7
The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.
Cancer Res. 1970 Jun;30(6):1789-94.
8
Criteria associated with destruction of leukemia and solid tumor cells in animals.与动物体内白血病和实体瘤细胞破坏相关的标准。
Cancer Res. 1967 Dec;27(12):2636-45.
9
Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).阿糖胞苷（NSC - 63878）加5 -（3,3 - 二甲基 - 1 - 三氮烯）咪唑 - 4 - 甲酰胺（NSC - 45388）疗法在晚期小鼠L1210白血病中的价值以及与甲氨蝶呤（NSC - 740）或1,3 - 双（2 - 氯乙基）-1 - 亚硝基脲（卡莫司汀；NSC - 409962）序贯剂量联合使用时疗效的增强。
Cancer Chemother Rep. 1973 Sep-Oct;57(3):291-8.
10
Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.有丝分裂周期抑制剂对携带白血病L1210的小鼠中阿糖胞苷（NSC - 63878）抗白血病活性的影响。
Cancer Chemother Rep. 1971 Dec;55(5):547-55.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验